Xiujuan Qu
Clinical trials sponsored by Xiujuan Qu, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New blood test may predict colorectal cancer recurrence Results expected Mar 2027 (estimated)
- New hope for hard-to-treat cancers: triple-drug combo targets HER2-positive tumors Results expected Jul 2027 (estimated)